1 Spieker MR. Evaluating Dysphagia. Am Fam Physician. 200015;61(12):3639–48.
2 Schweizer V. Troubles de la déglutition de la personne âgée. Rev Med Suisse 2010; 1859–62.
3 Loyd RA, McClellan DA. Update on the Evaluation and Management of Functional Dyspepsia. Am Fam Physician. 2011;83(5):547–52.
4 Nijrolder I, van der Windt D, de Vries H, van der Horst H. Diagnoses during follow-up of patients presenting with fatigue in primary care. CMAJ. 2009;181(10):683–7.
6 Malagelada J, Bazzoli F, Boeckxstaens G, De Looze D, Fried M, Kahrilas P, et al. World Gastroenterology Organisation [Internet].World Gastroenterology Organisation Global Guidelines: Dysphagia. Available from:
http://www.worldgastroenterology.org/guidelines/global-guidelines/dysphagia/dysphagia-english
7 Sieb JP. Myasthenia gravis: an update for the clinician. Clinical and Experimental Immunology. 2014;175(3):408–18.
8 Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol. 2004;24(1):17–20.
9 Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46.
10 Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, et al. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol. 2012;259(3):427–35.
11 Suzuki S, Utsugisawa K, Yoshikawa H,Motomura S, Yokoyama K, Nagane Y, et al. Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis. Arch Neurol. 2009;66(11):1334–8.
12 Shivamurthy P, Parker MW. Cardiac manifestations of myasthenia gravis: A systematic review. IJC Metabolic & Endocrine. 2014;5:3–6. Available from:
https://www.sciencedirect.com/science/article/pii/S2214762414000255.